MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesotheliomaCELL DEATH DISCOVERYIF72023-02-107OAAI
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancerMODERN PATHOLOGYIF5.52022-12-0117OAAI
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 PatientsJTO CLINICAL AND RESEARCH REPORTSIF3.52022-11-011OA
Tepotinib in patients with MET exon 14 skipping NSCLC: Efficacy and safety by line of therapyANNALS OF ONCOLOGYIF65.42022-04-011OA
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutationsEUROPEAN JOURNAL OF CANCERIF7.12021-12-0128OAAI
Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant TherapyCELLSIF5.22021-10-136OAAI
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological responseMODERN PATHOLOGYIF5.52021-07-0123OAAI
Immunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trialANNALS OF ONCOLOGYIF65.42020-09-011OAAI
Comparison of the 7th and 8th Edition of the UICC/AJCC TNM Staging System in Primary Resected Squamous Cell Carcinomas of the Lung-A Single Center Analysis of 354 CasesFRONTIERS IN MEDICINEIF32019-09-0417OAAI
Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective studyRADIATION ONCOLOGYIF3.22017-12-228OAAI